HAP Trading’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-32,500
Closed -$3.25K 919
2024
Q4
$3.25K Buy
+32,500
New +$1.85M ﹤0.01% 672
2024
Q3
Sell
-165,000
Closed -$21.6K 821
2024
Q2
$21.6K Sell
165,000
-85,000
-34% -$5.57M ﹤0.01% 523
2024
Q1
$491K Buy
+250,000
New +$11.1M 0.06% 187
2023
Q1
Sell
-41,300
Closed -$140K 1707
2022
Q4
$140K Sell
41,300
-1,400
-3% -$6.25K 0.01% 528
2022
Q3
$7K Buy
42,700
+3,900
+10% +$12.8K ﹤0.01% 1401
2022
Q2
$12K Sell
38,800
-4,600
-11% -$11.4K ﹤0.01% 1449
2022
Q1
$19K Buy
43,400
+28,100
+184% +$101K ﹤0.01% 1600
2021
Q4
$7K Sell
15,300
-2,300
-13% -$12.9K ﹤0.01% 2157
2021
Q3
$6K Buy
+17,600
New +$109K ﹤0.01% 2147
2019
Q3
Sell
-11,700
Closed -$3K 1431
2019
Q2
$3K Sell
11,700
-34,700
-75% -$297K ﹤0.01% 1050
2019
Q1
$58K Buy
46,400
+33,400
+257% +$280K 0.01% 643
2018
Q4
$8K Buy
+13,000
New +$155K ﹤0.01% 980
2018
Q3
Sell
-16,200
Closed -$38K 1179
2018
Q2
$38K Buy
+16,200
New +$108K ﹤0.01% 726

Other funds holding VKTX